title: Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation.
abstract: This paper describes the trends in haematopoietic stem cell transplantation (HSCT) activity for children in Europe over the last three decades. We analysed 31,713 consecutive paediatric HSCTs reported by the European Group for Blood and Marrow Transplantation (EBMT) centres between 1970 and 2002. Data were taken from the EBMT registry and were compared according to period and centre category (paediatric or combined). Since 1996, there has been a significant increase in the number of HSCTs performed exclusively by paediatric centres, as well as in the number of alternative donor HSCTs, and in the use of peripheral blood stem cells (P<0.0001). The number of allogeneic HSCTs (allo-HSCTs) for acute lymphoblastic leukaemia, acute myeloblastic leukaemia and chronic myeloid leukaemia remained stable, whereas it increased for myelodysplastic syndromes and lymphomas, and decreased significantly for non-malignant diseases (P<0.0001). Multivariate analysis showed that younger age, human leukocyte antigen genoidentical donors, HSCT performed after 1996 and transplant centres performing more than 10 allo-HSCT/year were all associated with decreased transplant-related mortality (TRM) (P<0.0001). The number of autologus HSCTs (auto-HSCTs) for acute leukaemia decreased significantly, whereas it increased for solid tumours (P<0.0001). Multivariate analysis showed that both auto-HSCT performed before 1996 and paediatric solid tumours (P<0.0001) had higher TRM. Indications for paediatric HSCT have changed considerably during the last seven years. These changes provide tools for decision making in health-care planning and counselling.
authors.affiliation: Department of Paediatric Haematology and Oncology, IRCSS Giannina Gaslini, Genova, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Miano
authors.forename: M
authors.initials: M
authors.lastname: Labopin
authors.forename: O
authors.initials: O
authors.lastname: Hartmann
authors.forename: E
authors.initials: E
authors.lastname: Angelucci
authors.forename: J
authors.initials: J
authors.lastname: Cornish
authors.forename: E
authors.initials: E
authors.lastname: Gluckman
authors.forename: F
authors.initials: F
authors.lastname: Locatelli
authors.forename: A
authors.initials: A
authors.lastname: Fischer
authors.forename: R M
authors.initials: RM
authors.lastname: Egeler
authors.forename: R
authors.initials: R
authors.lastname: Or
authors.forename: C
authors.initials: C
authors.lastname: Peters
authors.forename: J
authors.initials: J
authors.lastname: Ortega
authors.forename: P
authors.initials: P
authors.lastname: Veys
authors.forename: P
authors.initials: P
authors.lastname: Bordigoni
authors.forename: A P
authors.initials: AP
authors.lastname: Iori
authors.forename: D
authors.initials: D
authors.lastname: Niethammer
authors.forename: V
authors.initials: V
authors.lastname: Rocha
authors.forename: G
authors.initials: G
authors.lastname: Dini
mesh_terms: D001803:Blood Transfusion / Q000706:statistics & numerical data; D016026:Bone Marrow Transplantation / Q000706:statistics & numerical data; D002648:Child; D003625:Data Collection; D005060:Europe; D018380:Hematopoietic Stem Cell Transplantation / Q000706:statistics & numerical data*; D006801:Humans; D007938:Leukemia / Q000628:therapy; D012042:Registries; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous